Cerus' Institutional Investor Meeting

October 16, 2018
Time: 09:30 AM EST

Cerus will host an Institutional Investor Meeting on Tuesday, October 16, 2018 in Boston, Massachusetts.

The program will include presentations by Cerus’ executive team covering the Company’s business strategy and long term revenue growth drivers. Cerus will also provide a detailed update on its development programs including the red blood cell system as well as pathogen-reduced cryoprecipitate. In addition, guest speakers will provide clinical perspectives on the blood component transfusion industry.

Registration begins at 9:00 a.m. ET with presentations starting at 9:30 a.m. ET and concluding at approximately 12:00 noon ET.

Institutional investors and analysts are invited to attend in person and are encouraged to register in advance by emailing Investor Relations at ir@cerus.com.

    Global Headquarters

  • 1220 Concord Avenue
  • Concord, CA US 94520
  • +1 925.288.6000

    European Headquarters

  • Stationsstraat 79-D
  • 3811 MH Amersfoort, Netherlands
  • +31 (0) 33 49 60 600